Position in VTRS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,191
+$165 QoQ
Shares Held
75
-1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#914
of 1,016 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$958
PutShares
110
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Quaker Wealth Management, LLC holds $35,373 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
1,592 | $14,853 | |
| 2 | ZTS |
Zoetis Inc.
|
98 | $7,042 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
200 | $6,934 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7 | $3,792 | |
| 5 | VTRS |
Viatris Inc
This page
|
75 | $1,191 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
30 | $738 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
4 | $674 | |
| 8 | CGC |
Canopy Growth Corp
|
100 | $95 |
All Filings in VTRS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,191 | 75 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,026 | 76 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $871 | 70 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $603 | 61 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,098 | 123 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $958 | 110 | Put | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||